[go: up one dir, main page]

FI943376L - Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina - Google Patents

Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina Download PDF

Info

Publication number
FI943376L
FI943376L FI943376A FI943376A FI943376L FI 943376 L FI943376 L FI 943376L FI 943376 A FI943376 A FI 943376A FI 943376 A FI943376 A FI 943376A FI 943376 L FI943376 L FI 943376L
Authority
FI
Finland
Prior art keywords
phenylimidazolidinone
derivatives
preparation
receptor antagonists
antagonists
Prior art date
Application number
FI943376A
Other languages
English (en)
Swedish (sv)
Other versions
FI943376A0 (fi
FI943376A7 (fi
Inventor
Mario Varasi
Franco Heidempergher
Carla Caccia
Claudio Arrigoni
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of FI943376A0 publication Critical patent/FI943376A0/fi
Publication of FI943376L publication Critical patent/FI943376L/fi
Publication of FI943376A7 publication Critical patent/FI943376A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI943376A 1992-11-18 1993-10-22 Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina FI943376A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224144A GB9224144D0 (en) 1992-11-18 1992-11-18 Phenyl-imidazolidinone derivatives and process for their preparation
PCT/EP1993/002924 WO1994011347A1 (en) 1992-11-18 1993-10-22 Phenyl-imidazolidinone derivatives, process for their preparation and their use as 5ht3 receptor antagonists

Publications (3)

Publication Number Publication Date
FI943376A0 FI943376A0 (fi) 1994-07-15
FI943376L true FI943376L (fi) 1994-07-15
FI943376A7 FI943376A7 (fi) 1994-07-15

Family

ID=10725269

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943376A FI943376A7 (fi) 1992-11-18 1993-10-22 Fenyyli-imidatsolidinonijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT3-reseptoriantagonisteina

Country Status (19)

Country Link
US (1) US5424328A (fi)
EP (1) EP0623114B1 (fi)
JP (1) JP3794696B2 (fi)
CN (1) CN1093702A (fi)
AT (1) ATE179701T1 (fi)
AU (1) AU666793B2 (fi)
CA (1) CA2127536C (fi)
DE (1) DE69324794T2 (fi)
ES (1) ES2133415T3 (fi)
FI (1) FI943376A7 (fi)
GB (1) GB9224144D0 (fi)
HU (1) HUT70395A (fi)
IL (1) IL107371A (fi)
NZ (1) NZ257117A (fi)
PL (1) PL174416B1 (fi)
RU (1) RU2126403C1 (fi)
TW (1) TW233297B (fi)
WO (1) WO1994011347A1 (fi)
ZA (1) ZA938206B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780492A (en) * 1996-04-03 1998-07-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6455424B1 (en) * 2000-08-07 2002-09-24 Micron Technology, Inc. Selective cap layers over recessed polysilicon plugs
EP2858501A4 (en) * 2012-05-22 2015-12-09 Merck Sharp & Dohme TRKA KINASE INHIBITORS, COMPOSITIONS AND METHOD THEREFOR

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459757A (en) * 1965-10-22 1969-08-05 American Cyanamid Co Imidazolidines
US3491098A (en) * 1967-05-29 1970-01-20 Sterling Drug Inc 1-((imidazolyl)-lower-alkyl)-4-substituted-piperazines
US3702327A (en) * 1970-12-28 1972-11-07 Aldrich Chem Co Inc N-beta-1-(3-phenylimidazolidin-2-one)ethyl 4,4-ethylene dioxypiperidines
JPS6133172A (ja) * 1984-07-24 1986-02-17 Kotobuki Seiyaku Kk 1,3−置換−2−イミダゾリジノン誘導体,胃腸運動亢進剤及びその製造方法
US4600430A (en) * 1985-02-22 1986-07-15 Eli Lilly And Company Pyridinylimidazolidinone compounds
JPS62135464A (ja) * 1985-12-10 1987-06-18 Nippon Kayaku Co Ltd フエニルピペラジン誘導体
FI90869C (fi) * 1986-11-14 1994-04-11 Tanabe Seiyaku Co Menetelmä lääkeaineena käyttökelpoisten imidatsolidinonijohdannaisten valmistamiseksi
GB8812002D0 (en) * 1988-05-20 1988-06-22 Glaxo Group Ltd Chemical compounds
GB8720693D0 (en) * 1987-09-03 1987-10-07 Glaxo Group Ltd Chemical compounds
AU611976B2 (en) * 1987-12-24 1991-06-27 John Wyeth & Brother Limited Aroyl urea and carbamic acid derivatives of azabicyclo compounds
IT1230703B (it) * 1989-01-26 1991-10-29 Luso Farmaco Inst Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
GB2248058B (en) * 1990-09-21 1994-09-14 Orion Yhtymae Oy Aromatase inhibiting 4(5)-imidazoles
GB9106571D0 (en) * 1991-03-27 1991-05-15 Erba Carlo Spa Derivatives of substituted imidazol-2-one and process for their preparation
GB9020889D0 (en) * 1990-09-25 1990-11-07 May & Baker Ltd New compositions of matter
IT1255802B (it) * 1992-08-07 1995-11-16 Luso Farmaco Inst Derivati imidazolici ad attivita' a ii antagonista

Also Published As

Publication number Publication date
TW233297B (fi) 1994-11-01
IL107371A0 (en) 1994-01-25
AU5336494A (en) 1994-06-08
WO1994011347A1 (en) 1994-05-26
ES2133415T3 (es) 1999-09-16
HUT70395A (en) 1995-10-30
AU666793B2 (en) 1996-02-22
DE69324794T2 (de) 1999-12-02
FI943376A0 (fi) 1994-07-15
JP3794696B2 (ja) 2006-07-05
PL174416B1 (pl) 1998-07-31
ZA938206B (en) 1994-06-10
RU94036775A (ru) 1996-05-27
NZ257117A (en) 1995-08-28
RU2126403C1 (ru) 1999-02-20
EP0623114B1 (en) 1999-05-06
US5424328A (en) 1995-06-13
JPH07503256A (ja) 1995-04-06
HU9401948D0 (en) 1994-09-28
PL304676A1 (en) 1995-01-09
GB9224144D0 (en) 1993-01-06
DE69324794D1 (de) 1999-06-10
FI943376A7 (fi) 1994-07-15
EP0623114A1 (en) 1994-11-09
CA2127536C (en) 2005-09-06
CA2127536A1 (en) 1994-05-26
ATE179701T1 (de) 1999-05-15
CN1093702A (zh) 1994-10-19
IL107371A (en) 1998-02-08

Similar Documents

Publication Publication Date Title
FI972583A0 (fi) Tetrasyklisiä spiroyhdisteitä, menetelmä niiden valmistamiseksi ja niiden käyttö 5HT1D-reseptoriantagonisteina
FI951722A7 (fi) Uudet substituoidut pyratsolijohdannaiset, menetelmät niiden valmistam iseksi ja niiden käyttö herbisideinä
FI982761L (fi) Bentsimidatsolijohdannaiset, niiden valmistus ja kiteet
EE03231B1 (et) Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine
FI903215A7 (fi) Heteroaryyliamino- ja heteroaryylioksipyridiiniamiineja ja niihin liittyviä yhdisteitä, menetelmä niiden valmistamiseksi sekä niiden käyttö lääkkeinä
FI944729L (fi) Perhydroisoindolijohdannaiset substanssi P:n antagonisteina
FI944394A7 (fi) Kinuklidiinijohdannaisia P-aineen antagonisteina
FI904419A7 (fi) 3-(1-substituoituja-4-piperatsinyyli)-1H-indatsoleja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
FI920017A7 (fi) Atsolijohdoksia, menetelmiä niiden valmistamiseksi ja niiden käyttö
IL98470A0 (en) Substituted benzimidazoles,process for their preparation and their pharmaceutical use
FI931499A7 (fi) Syklopeptidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääke aineina
IT1229523B (it) Derivati isochinolinici, procedimento per la loro preparazione ed impiego
FI930633A7 (fi) Bensimidatsolijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FI915381A7 (fi) Substituoituja atsoleja, menetelmä niiden valmistamiseksi ja niiden käyttö
FI924869A7 (fi) Kinoliinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden terapeuttinen käyttö
FI933544A7 (fi) Tiadiatsiinikarboksamidijohdannaiset, menetelmät niiden valmistamiseks i ja lääkkeet
FI951798A7 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
FI943808A7 (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vast avaikuttajina
FI942912A7 (fi) Substituoidut bentsimidatsolit, menetelmä niiden valmistamiseksi sekä niiden käyttö
FI915435A7 (fi) Uusia leukotrieeni-B4-johdannaisia, menetelmiä niiden valmistamiseksi ja niiden käyttö lääkeaineina
FI931881A7 (fi) Merkityt fibrinogeeni-reseptori-antagonistit, niiden käyttö ja menetelmä niiden valmistamiseksi
FI922903A7 (fi) 4-asetoksipiperidiinijohdannaiset, niiden valmistusmenetelmä ja käyttö muskariinisen M3-reseptorin antagonistina
FI901295A7 (fi) 2-halogeenisyklopropaanijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö tuholaistentorjunta-aineina
FI924053A7 (fi) Substituoidut aminopropaanit, menetelmä niiden valmistamiseksi ja niiden käyttö

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.

FD Application lapsed